PL2137196T3 - Tricykliczne związki zawierające azot jako środki przeciwbakteryjne - Google Patents

Tricykliczne związki zawierające azot jako środki przeciwbakteryjne

Info

Publication number
PL2137196T3
PL2137196T3 PL08749580T PL08749580T PL2137196T3 PL 2137196 T3 PL2137196 T3 PL 2137196T3 PL 08749580 T PL08749580 T PL 08749580T PL 08749580 T PL08749580 T PL 08749580T PL 2137196 T3 PL2137196 T3 PL 2137196T3
Authority
PL
Poland
Prior art keywords
containing compounds
antibacterial agents
nitrogen containing
tricyclic nitrogen
tricyclic
Prior art date
Application number
PL08749580T
Other languages
English (en)
Inventor
David Evan Davies
David Thomas Davies
Ilaria Giordano
Alan Joseph Hennessy
Neil David Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2137196(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0707705A external-priority patent/GB0707705D0/en
Priority claimed from GB0720569A external-priority patent/GB0720569D0/en
Priority claimed from GB0805311A external-priority patent/GB0805311D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PL2137196T3 publication Critical patent/PL2137196T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL08749580T 2007-04-20 2008-04-16 Tricykliczne związki zawierające azot jako środki przeciwbakteryjne PL2137196T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0707705A GB0707705D0 (en) 2007-04-20 2007-04-20 Compounds
GB0720569A GB0720569D0 (en) 2007-10-19 2007-10-19 Compounds
GB0805311A GB0805311D0 (en) 2008-03-20 2008-03-20 Compounds
PCT/EP2008/054621 WO2008128942A1 (en) 2007-04-20 2008-04-16 Tricyclic nitrogen containing compounds as antibacterial agents
EP08749580A EP2137196B1 (en) 2007-04-20 2008-04-16 Tricyclic nitrogen containing compounds as antibacterial agents

Publications (1)

Publication Number Publication Date
PL2137196T3 true PL2137196T3 (pl) 2011-03-31

Family

ID=39580226

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08749580T PL2137196T3 (pl) 2007-04-20 2008-04-16 Tricykliczne związki zawierające azot jako środki przeciwbakteryjne

Country Status (31)

Country Link
US (1) US8389524B2 (pl)
EP (1) EP2137196B1 (pl)
JP (1) JP5389013B2 (pl)
KR (1) KR101567096B1 (pl)
CN (1) CN101687887B (pl)
AR (1) AR066111A1 (pl)
AT (1) ATE483717T1 (pl)
AU (1) AU2008240764C1 (pl)
BR (1) BRPI0810064B8 (pl)
CA (1) CA2684659C (pl)
CL (1) CL2008001122A1 (pl)
CO (1) CO6251368A2 (pl)
CR (2) CR11123A (pl)
CY (1) CY1111248T1 (pl)
DE (1) DE602008002912D1 (pl)
DK (1) DK2137196T3 (pl)
DO (1) DOP2009000240A (pl)
EA (1) EA015821B1 (pl)
HR (1) HRP20100574T1 (pl)
IL (1) IL201204A0 (pl)
MA (1) MA31324B1 (pl)
MX (1) MX2009011317A (pl)
MY (1) MY149347A (pl)
NZ (1) NZ579877A (pl)
PE (1) PE20090274A1 (pl)
PL (1) PL2137196T3 (pl)
PT (1) PT2137196E (pl)
SI (1) SI2137196T1 (pl)
TW (1) TWI431006B (pl)
UY (1) UY31038A1 (pl)
WO (1) WO2008128942A1 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1954697T3 (da) * 2005-10-21 2010-06-14 Glaxo Group Ltd Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
MY153979A (en) 2007-10-19 2015-04-30 Boehringer Ingelheim Int Substituted piperidino-dihydrothienopyrimidine
JP5563466B2 (ja) 2007-10-19 2014-07-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ピペラジノ−ジヒドロチエノピリミジン誘導体
BRPI0817781A2 (pt) 2007-10-19 2019-09-24 Boehringer Ingelheim Int piperazino-diidroteinopirimidinas substituídas com heterociclo
EP2257551B1 (en) 2008-02-20 2013-04-10 Actelion Pharmaceuticals Ltd. Azatricyclic antibiotic compounds
WO2009141398A1 (en) * 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
JP2011520944A (ja) * 2008-05-23 2011-07-21 グラクソ グループ リミテッド 窒素含有三環式化合物および抗菌剤としてのその使用
WO2010041194A1 (en) 2008-10-07 2010-04-15 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
US20110275661A1 (en) * 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
WO2010083328A2 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
CA2797708C (en) * 2010-05-04 2016-08-16 Alkermes Pharma Ireland Limited Process for synthesizing oxidized lactam compounds
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
WO2015012210A1 (ja) * 2013-07-23 2015-01-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ縮合環化合物
EP3182973B1 (en) 2014-08-22 2019-09-18 GlaxoSmithKline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
GEP20207167B (en) * 2016-06-22 2020-10-12 Univ Vanderbilt Positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2018195098A1 (en) 2017-04-17 2018-10-25 Ohio State Innovation Foundation Type ii topoisomerase inhibitors and methods of making and using thereof
EP3946342A1 (en) 2019-04-03 2022-02-09 GlaxoSmithKline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial urinary tract infections
BR112021024845A2 (pt) * 2019-07-05 2022-01-18 Glaxosmithkline Ip Dev Ltd Combinação para o tratamento de infecções causadas por mycoplasma genitalium
EP4125905B1 (en) 2020-04-02 2024-12-25 GlaxoSmithKline Intellectual Property Development Limited Regimen for treating a neisseria gonorrhoeae infection with gepotidacin
US20230167113A1 (en) * 2020-04-29 2023-06-01 Glaxosmithkline Intellectual Property Development Limited Crystalline forms of gepotidacin
CN111494241B (zh) * 2020-06-01 2023-03-24 湖北洁世达环保科技有限公司 一种纸巾柔润保湿液
BR112023015676A2 (pt) 2021-02-05 2023-10-17 Glaxosmithkline Ip Dev Ltd Formulações orais em dose sólida
US20250099535A1 (en) 2022-01-21 2025-03-27 Glaxosmithkline Intellectual Property Development Limited Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus
EP4316463A1 (en) 2022-08-02 2024-02-07 GlaxoSmithKline Intellectual Property Development Limited Novel formulation
JP2025532252A (ja) 2022-09-26 2025-09-29 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 処置方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403610B1 (en) * 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
PL366335A1 (pl) * 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperydynochinoliny ich azaizosteryczne analogi o przeciwbakteryjnej aktywności
US6603005B2 (en) * 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (en) * 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2002350217A1 (en) * 2001-12-04 2003-06-17 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
JP4445753B2 (ja) * 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
EP1470131A2 (en) * 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
BR0315221A (pt) * 2002-10-10 2005-08-23 Morphochem Ag Komb Chemie Compostos com atividade antibacteriana
WO2004096982A2 (en) * 2002-11-05 2004-11-11 Smithkline Beecham Corporation Antibacterial agents
JP4654035B2 (ja) * 2002-11-05 2011-03-16 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
US7232833B2 (en) * 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7348434B2 (en) * 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008502689A (ja) * 2004-06-15 2008-01-31 グラクソ　グループ　リミテッド 抗菌剤
FR2872164B1 (fr) * 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008505920A (ja) 2004-07-08 2008-02-28 グラクソ　グループ　リミテッド 抗菌剤
US20080194547A1 (en) * 2004-07-09 2008-08-14 Glaxo Group Limited Antibacterial Agents
JP2008506695A (ja) * 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
EP1778688A1 (en) 2004-07-22 2007-05-02 Glaxo Group Limited Antibacterial agents
DE602005024151D1 (de) * 2004-08-02 2010-11-25 Glaxo Group Ltd Antibakterielle mittel
JP2008509222A (ja) * 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
CA2580621A1 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
CN101039935B (zh) * 2004-10-05 2011-04-20 埃科特莱茵药品有限公司 哌啶抗生素
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
US7648980B2 (en) * 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
JP2008528587A (ja) * 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
JP2008528588A (ja) * 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
JP2008528598A (ja) * 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7511035B2 (en) * 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
US7842810B2 (en) * 2005-03-31 2010-11-30 Janssen Pharmaceutica, Nv Bicyclic pyrazole compounds as antibacterial agents
US20090131444A1 (en) * 2005-05-24 2009-05-21 Astrazeneca Ab Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
ES2330670T3 (es) * 2005-05-25 2009-12-14 Actelion Pharmaceuticals Ltd. Nuevos derivados antibioticos.
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
DK1954697T3 (da) * 2005-10-21 2010-06-14 Glaxo Group Ltd Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
WO2007071936A1 (en) * 2005-12-22 2007-06-28 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
JP2009532504A (ja) * 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
US7709483B2 (en) * 2006-04-06 2010-05-04 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
WO2008006648A1 (en) * 2006-06-09 2008-01-17 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0705672D0 (en) * 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (en) * 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707708D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (en) * 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
GB0800367D0 (en) * 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
BRPI0810064B8 (pt) 2021-05-25
JP2010524884A (ja) 2010-07-22
KR20100017133A (ko) 2010-02-16
NZ579877A (en) 2011-09-30
US20100137282A1 (en) 2010-06-03
IL201204A0 (en) 2010-05-17
TW200848420A (en) 2008-12-16
AU2008240764A1 (en) 2008-10-30
KR101567096B1 (ko) 2015-11-06
CY1111248T1 (el) 2015-06-11
EP2137196A1 (en) 2009-12-30
AU2008240764B2 (en) 2011-04-07
DK2137196T3 (da) 2011-01-10
AU2008240764C1 (en) 2011-10-20
EP2137196B1 (en) 2010-10-06
DOP2009000240A (es) 2009-12-31
BRPI0810064B1 (pt) 2021-03-30
CO6251368A2 (es) 2011-02-21
PT2137196E (pt) 2010-12-16
TWI431006B (zh) 2014-03-21
DE602008002912D1 (de) 2010-11-18
BRPI0810064A2 (pt) 2019-08-27
PE20090274A1 (es) 2009-04-03
CN101687887A (zh) 2010-03-31
CA2684659A1 (en) 2008-10-30
ATE483717T1 (de) 2010-10-15
CN101687887B (zh) 2012-08-29
CA2684659C (en) 2015-11-24
MX2009011317A (es) 2009-11-05
HRP20100574T1 (hr) 2010-12-31
HK1138000A1 (en) 2010-08-13
SI2137196T1 (sl) 2011-01-31
MA31324B1 (fr) 2010-04-01
UY31038A1 (es) 2008-11-28
MY149347A (en) 2013-08-30
EA200970987A1 (ru) 2010-04-30
CR11123A (es) 2010-03-08
JP5389013B2 (ja) 2014-01-15
AR066111A1 (es) 2009-07-22
CR20150586A (es) 2016-04-04
CL2008001122A1 (es) 2008-10-24
WO2008128942A1 (en) 2008-10-30
US8389524B2 (en) 2013-03-05
EA015821B1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
IL201204A0 (en) Tricyclic nitrogen containing compounds as antibacterial agents
IL198865A0 (en) Antibacterial polycyclic urea compounds
IL209434A0 (en) Novel tricyclic compounds
EP1988091A4 (en) TRICYCLIC CONNECTIONS
GB0821913D0 (en) Antibacterial compounds
TWI347842B (en) Tricyclic compounds, compositions, and methods
EP1863483A4 (en) Bicyclic pyrazole compounds as anti-bacteriostatic agents
ZA201000474B (en) Polycyclic compound
GB0724278D0 (en) uses for antimicrobial agents
GB0724349D0 (en) Antibacterial agents
IL189322A0 (en) Oxazolidinone-quinolone hydrids as antibacterial compounds
SI1954697T1 (sl) Peri kondenzirane triciklične spojine uporabne kot antibakterijska sredstva
GB0718735D0 (en) Antibacterial agents
SI2235041T1 (sl) Antimikrobne spojine
IL209270A0 (en) Tricyclic nitrogen containing compounds and their use as antibacterials
ZA200809821B (en) Novel antibacterial compounds
EP2327690A4 (en) TRICYCLIC CONNECTION
ZA200906607B (en) Tricyclic nitrogen containing compounds as antibacterial agents
PL2321306T3 (pl) 3-cyjanopirolidynylo-fenylo-oksazolidynony jako środki przeciwbakteryjne
EP2189443A4 (en) TRICYCLIC AMIDE COMPOUND
GB0705944D0 (en) Organic compounds
GB0705931D0 (en) Organic compounds
GB0803060D0 (en) Novel antimicrobial compounds
GB0823284D0 (en) Novel antimicrobial compounds
GB0718738D0 (en) Antibacterial agents